J1930 Lanreotide Acetate - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Lanreotide Acetate

Brand Name:

Somatuline Depot

Strength:

1 mg

HCPCS:

J1930

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Somatostatin Analog

Minor Drug Class:

Oral (Y/N):

No

FDA Approval Year:

2007

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2009

CMS Discontinuation Date:

Status:

In Use